首页> 外文会议>International Conference on Advanced Fibers and Polymer Materials;ICAFPM >Nanofibers-based DDS electrospun from co-dissolving solutions of Eudragit L-100 and diclofenac sodium
【24h】

Nanofibers-based DDS electrospun from co-dissolving solutions of Eudragit L-100 and diclofenac sodium

机译:从Eudragit L-100和双氯芬酸钠共同溶解的溶液中静电纺制基于纳米纤维的DDS

获取原文

摘要

The paper presents the preparation and characterization of nanofibers-based drug delivery systems (DDS) electrospun from co-dissolving solutions of Eudragit L100 and diclofenac sodium (DS). Eudragit L-100 and DS could well co-dissolve in a mixed solvent of methanol and dimethylacetamide (DMAc) with a volume ratio of 6 to 1 for preparing the spinning solutions. Scanning electron microscope (SEM) was carried out to observe the morphology of the nanofibers. Fourier-transform infrared (FTIR) was conducted to clarify the interactions between the drug and the matrix polymer. Drug release profiles were investigated using in vitro dissolution tests. Results from SEM showed that the drug was distributed evenly in Eudragit L-100 nanofibers. FT-IR results demonstrated that the main interactions between Eudragit L-100 and DS were hydrogen bonding. The in vitro dissolution tests showed that drug release rate from drug-loaded nanofibers mainly depended on the pH value of the dissolution media. Drug-loaded Eudragit L-100 nanofibers could be promising for preparing colon-targeted DDS.
机译:本文介绍了从Eudragit L100和双氯芬酸钠(DS)的共溶溶液中静电纺丝的基于纳米纤维的药物递送系统(DDS)的制备和表征。 Eudragit L-100和DS可以很好地共溶在甲醇和二甲基乙酰胺(DMAc)的混合溶剂中,以6:1的体积比制备纺丝溶液。进行扫描电子显微镜(SEM)以观察纳米纤维的形态。进行了傅里叶变换红外(FTIR),以阐明药物与基质聚合物之间的相互作用。使用体外溶出试验研究了药物释放曲线。扫描电镜结果表明,该药物均匀分布在Eudragit L-100纳米纤维中。 FT-IR结果表明Eudragit L-100与DS之间的主要相互作用是氢键。体外溶出试验表明,载药纳米纤维的释药速率主要取决于溶出介质的pH值。载有药物的Eudragit L-100纳米纤维有望用于制备靶向结肠的DDS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号